Species Differences in Microsomal Metabolism of Xanthine-Derived A<sub>1</sub> Adenosine Receptor Ligands
Tracer development for positron emission tomography (PET) requires thorough evaluation of pharmacokinetics, metabolism, and dosimetry of candidate radioligands in preclinical animal studies. Since variations in pharmacokinetics and metabolism of a compound occur in different species, careful selecti...
Saved in:
Main Authors: | Daniela Schneider (Author), Dirk Bier (Author), Marcus Holschbach (Author), Andreas Bauer (Author), Bernd Neumaier (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relevance of In Vitro Metabolism Models to PET Radiotracer Development: Prediction of In Vivo Clearance in Rats from Microsomal Stability Data
by: Daniela Schneider, et al.
Published: (2019) -
Synthesis of Novel Fluorinated Xanthine Derivatives with High Adenosine A<sub>2B</sub> Receptor Binding Affinity
by: Marcel Lindemann, et al.
Published: (2021) -
Curcumin Stereoisomer, Cis-Trans Curcumin, as a Novel Ligand to A<sub>1</sub> and A<sub>3</sub> Adenosine Receptors
by: Luke J. Hamilton, et al.
Published: (2023) -
Tumor Immunotherapy Using A<sub>2A</sub> Adenosine Receptor Antagonists
by: Jinfeng Zhang, et al.
Published: (2020) -
A<sub>3</sub> Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
by: Andrea Spinaci, et al.
Published: (2022)